Elevance Health Inc. Stock News

Sector components forecast to show the biggest earnings year-over-year earnings improvement include Humana Inc. NYSE: HUM, Elevance Health Inc. NYSE: ELV, Incyte Corp. NASDAQ: INCY, Insulet Corp.

Elevance Health (ELV) expects 2024 premium revenues to remain in line with the 2023 level.

While the top- and bottom-line numbers for Elevance Health (ELV) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics

Elevance Health (ELV) came out with quarterly earnings of $5.62 per share, beating the Zacks Consensus Estimate of $5.55 per share. This compares to earnings of $5.23 per share a year ago.

Elevance Health reported fourth-quarter sales that beat analysts' estimates on Wednesday, helped by higher premiums from its health insurance business and demand at its Carelon health services busines

Get a deeper insight into the potential performance of Elevance Health (ELV) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimate

Elevance Health's (ELV) fourth-quarter results are likely to reflect higher premiums and product revenues.

Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and HealthEquity (HQY). But which of these two companies is the best option for those looking f

Here is how Elevance Health (ELV) and Axonics Modulation Technologies (AXNX) have performed compared to their sector so far this year.

Elevance's (ELV) Carelon unit is expected to benefit from improving performance in the Behavioral Health business and post-acute care services.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

In the closing of the recent trading day, Elevance Health (ELV) stood at $475.12, denoting a -1.49% change from the preceding trading day.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Elevance Health (ELV) launches a new program with an Affordable Connectivity Program offering free smartphones to eligible members.

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release fourth quarter and full year 2023 financial results on January 24, 2024 at 6:00 a.m. Eastern Daylight Time (“EDT”). Manageme